Antibody

• US 20070274985A1
• Filed: 05/26/2006
• Published: 11/29/2007
• Est. Priority Date: 05/26/2006
• Status: Abandoned Application

• Current Assignee: Technische Universitat Munchen
• Original Assignee: Technische Universitat Munchen
• Inventors: Hust, Michael, Dubel, Stefan, Jostock, Thomas, Kirsch, Martina Inga, Meier, Doris
• Application Number:
  US11/442,470
• Publication Number:
  US 20070274985A1
• Time in Patent Office: Days
• US Class Current: 424/133.100
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: C07K 2317/21 from primates, e.g. man
• CPC Class Codes: C07K 2317/55 Fab or Fab'
• CPC Class Codes: C07K 2317/622 Single chain antibody (scFv)
• CPC Class Codes: C07K 2319/00 Fusion polypeptide

Abstract

The present invention refers to synthetic antibody molecules which comprise domains from naturally occuring antibodies, e.g. domains derivable from IgG, preferably of human origin, in a novel arrangement. Single chain molecules are provided which are suitable for expression in micro-organisms in their active conformation, which single chain molecules generally comprise a VL domain, a CL domain, and a VH domain, a CH1 domain, linked by a linker arranged between VUCL and VH/CH1. Accordingly, these antibody molecules can be termed single chain Fabs (scFabs). These antibody molecules are single chain proteins, which can also be associated to dimers, including heteromeric antibodies, wherein at least two single chain antibody molecules are associated.

Claims

1. A single chain protein having antibody specificity towards an antigen, comprising a first variable domain connected to a first constant domain, a linker, and a second variable domain connected to a second constant domain.

2. A single chain protein according to claim 1, wherein the first variable domain is a VL domain and the second variable domain is a VH domain.

3. A single chain protein according to claim 1, wherein the first variable domain is a VH domain and the second variable domain is a VL domain.

4. A single chain protein according to claim 1, wherein the first constant domain is a CL domain, and the second constant domain is a CH1 domain.

5. A single chain protein according to claim 1, wherein the first constant domain is a CH1 domain, and the second constant domain is a CL domain.

6. A single chain protein according to claim 1, wherein the arrangement of domains is, from N-terminus to C-terminus of the following:

VL-CL-linker-VH-CH1 and VH-CH1 -linker-VL-CL.

7. A single chain protein according to claim 1, wherein the linker comprises from 5 to 40 amino acids in length.

8. A single chain protein according to claim 1, wherein at least one of the C-terminal cystein residues comprised in the first constant domain and comprised in the second constant domain is deleted.

9. A single chain protein according to claim 1, wherein the antigen specificity of the VL domain and of the VH domain are directed against the same antigen.

10. A single chain protein according to claim 1, wherein the antigen specificity of the VL domain and of the VH domain are directed against different antigens.

11. A single chain protein according to claim 1, comprising a signal peptide sequence directing the protein for secretion.

12. A single chain protein according to claim 1, having fused to its C-terminus an amino acid sequence selected from the group comprising the Fc portion of a natural immunoglobulin, a transmembrane region, a toxin, and RNase.

16. A single chain protein according to claim 1, having fused to its C-terminus an amino acid sequence comprising the Fc portion of an RNase.

13. An association of single chain proteins comprising at least one first single chain protein and at least one second single chain protein, wherein the first and the second single chain proteins comprise a VL domain connected to a CL domain, linked by a linker to a VH domain connected to a CH1 domain, wherein the linker comprises from 5 to 40 amino acids in length, and wherein the VH and VL domains of each single chain protein independently have the same or different antigen specificities.

14. An association of single chain proteins comprising at least one first single chain protein and at least one second single chain protein, wherein the first single chain protein comprises a VL domain connected to a CL domain, linked by a linker to a VH domain connected to a CH1 domain, wherein the linker comprises from 5 to 40 amino acids in length, the second single chain protein comprising a VH domain connected to a CH1 domain, linked by a linker to a VL domain connected to a CL domain, wherein the linker comprises from 5 to 40 amino acids in length, wherein the VH and VL domains of each single chain protein independently have the same or different antigen specificities.

15. An association of single chain proteins comprising at least one first single chain protein and at least one second single chain protein, wherein the first and the second single chain proteins comprise a VH domain connected to a CH1 domain, linked by a linker to a VL domain connected to a CL domain, wherein the linker comprises from 5 to 40 amino acids in length, and wherein the VH and VL domains of each single chain protein independently have the same or different antigen specificities.